Document 8RY0wjOV4YMoB8qbjq7GdE0Yd

El Ref Ares(2022)5570786- 04/08/2022 From: Sent: To: Cc: Subject: @kreab.com> lundi 4 mai 2020 11:18 (GROW) (GROW); FW: AGC - Meeting request on the PFHxA restriction proposal Dear - Thank you very much for your reply and the reminder of the different stages of the decisional process. AGC is well aware of the deadlines of the public consultation, and is in the process of elaborating its preliminary input, that will be submitted by 13 May. Thank you for proposing to forward AGC's contribution to you, we will do so when ready. Best regards, KREAB Found rd 1970 Direct Office +32 2 Mobile +32 counded 1970 Kreab 2/4, Rond-Point Schuman, BE-1040 Brussels, Belgium Tel +32 2 Mob +32 @kreab.com . .com EU Transparency Register ID Number: 107839051754 This communication is only intended for the use of the individual or entity, to which it is directed and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If received in error please notify us immediately, delete this email and destroy all copies. From: @ec.europa.eu @ec.europa.eu> Sent: jeudi 30 avril 2020 19:59 To: @kreab.com> Cc: @kreab.com>; @ec.europa.eu Subject: RE: AGC Meeting request on the PFHxA restriction proposal @kreab.com>; Dear Thank you very much for contacting us. At this stage of the restriction process, the Commission plays an observer role. Stakeholders can submit their contribution to the public consultation on the restriction dossier. Further discussion will take place in RAC and SEAC in order to assess and elaborate the restriction dossier, and also on these occasions stakeholders can contribute. I hope you are aware that public consultation for the PFHxA has already started on 25/3/ 2020 and finishes on the 25/9/2020 with a first deadline on the 13th of May. Finally, there will be a second public consultation on the SEAC draft opinion, which will look also at derogations. The full analysis will be reflected in the committees opinions, that ECHA will send to the Commission next year. Only at that point the Commission will become the main actor in the regulatory procedure. For these reasons, we do not find that a meeting at this specific point in time would be convenient. However, please forward also to us all the information the company has submitted to ECHA . We would like also to study beforehand the concerns of the AGC. Should you require any additional information, please do not hesitate to contact me. European Commission DG for Internal Market, Industry, Entrepreneurship and SMEs REACH BREY B1049 Brussels/Belgium +32 @ec.europa.eu Follow us on Facebook: EU Growth Twitter: @EU Growth Our Websites: ec.europa.eu/growth ec.europa.eu/bienkowska From: @kreab.com> Sent: Wednesday, April 22, 2020 6:17 PM To: (GROW) @ec.europa.eu>; @ec.europa.eu> Cc: @kreab.com>; Subject: RE: AGC Meeting request on the PFHxA restriction proposal (GROW) kreab.com> Dear , Dear Please allow me to follow up with you regarding the meeting request sent on behalf of AGC on the REACH restriction proposal for PFHxA, its salts, and PFHxArelated substances published by the German authorities last January. AGC imports and uses a C6 substance for the production of ETFE in its UK facility, that are then sold on the EU market. In the postBrexit context, future import of ETFE to the EU would fall under the scope of the REACH PFHxA restriction proposal. As such, AGC is in the process of requesting an exemption under the PFHxA restriction proposal to be able to continue placing ETFE products on the EU market. Additionally, AGC has other products, fluoropolymers and C6 fluorinated polymers, that will fall under the scope of the restriction proposal and for which exemption requests are in the process of being elaborated. AGC is currently compiling information on the use, control of emissions, alternatives, and possible socioeconomic impacts of the Restriction to submit comments to the public consultation. As meetings cannot take place due to the Covid19 situation, AGC's representatives would be happy to schedule a call with you to further discuss this issue in the course of May. We thank you for your consideration and look forward to hearing from you. Best regards, Kreab 2/4, RondPoint Schuman, BE1040 Brussels, Belgium Tel +32 2 Mob +32 @kreab.com www.kreab.com EU Transparency Register ID Number: 107839051754 This communication is only intended for the use of the individual or entity, to which it is directed and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If received in error please notify us immediately, delete this email and destroy all copies. From: Sent: vendredi 15 novembre 2019 17:49 To: @ec.europa.eu Cc: @kreab.com>; @kreab.com>; @ec.europa.eu Subject: RE: AGC Meeting request on the PFHxA restriction proposal Dear , Thank you for your reply. We completely understand and will come back to you on this issue at a later stage. Kind regards, From @ec.europa.eu Sent: vendredi 15 novembre 2019 17:22 To: @kreab.com> Cc: @ec.europa.eu> @kreab.com>; @kreab.com>; @ec.europa.eu Subject: RE: AGC Meeting request on the PFHxA restriction proposal Dear Thank you very much for the request sent. We would suggest to postpone for a while the meeting till we have a better view of the time of the proposal by the Dossier Submitter. Kind Regards European Commission DG for Internal Market, Industry, Entrepreneurship and SMEs REACH BREY B1049 Brussels/Belgium +32 229 @ec.europa.eu Follow us on Facebook: EU Growth Twitter: @EU Growth Our Websites: ec.europa.eu/growth ec.europa.eu/bienkowska From: @kreab.com> Sent: Friday, November 8, 2019 12:07 PM To: (GROW) @ec.europa.eu>; (GROW) @ec.europa.eu> Cc: @kreab.com>; @kreab.com> Subject: AGC Meeting request on the PFHxA restriction proposal Dear , Dear , Please allow me to contact you on behalf of the Japanese company AGC, regarding Germany's intention to submit a restriction proposal for PFHxA, its salts, and PFHxA related substances. AGC produces and uses various C6 substances, in particular a C6 processing aid for the production of ETFE in the United Kingdom. AGC is currently compiling information on the use, control of emissions, and possible impacts of an EU restriction. AGC representatives would be pleased to have the opportunity to discuss this issue with you in further detail, preferably on 27 November. However, further dates can be provided via email. We thank you in advance for your consideration, Best regards, Kreab 2/4, RondPoint Schuman, BE1040 Brussels, Belgium Tel +32 2 Mob +32 @kreab.com www.kreab.com EU Transparency Register ID Number: 107839051754 This communication is only intended for the use of the individual or entity, to which it is directed and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If received in error please notify us immediately, delete this email and destroy all copies.